Literature DB >> 20439707

C/EBP{delta} targets cyclin D1 for proteasome-mediated degradation via induction of CDC27/APC3 expression.

Snehalata A Pawar1, Tapasree Roy Sarkar, Kuppusamy Balamurugan, Shikha Sharan, Jun Wang, Youhong Zhang, Steven F Dowdy, A-Mei Huang, Esta Sterneck.   

Abstract

The transcription factor CCAAT/enhancer binding protein delta (C/EBPdelta, CEBPD, NFIL-6beta) has tumor suppressor function; however, the molecular mechanism(s) by which C/EBPdelta exerts its effect are largely unknown. Here, we report that C/EBPdelta induces expression of the Cdc27 (APC3) subunit of the anaphase promoting complex/cyclosome (APC/C), which results in the polyubiquitination and degradation of the prooncogenic cell cycle regulator cyclin D1, and also down-regulates cyclin B1, Skp2, and Plk-1. In C/EBPdelta knockout mouse embryo fibroblasts (MEF) Cdc27 levels were reduced, whereas cyclin D1 levels were increased even in the presence of activated GSK-3beta. Silencing of C/EBPdelta, Cdc27, or the APC/C coactivator Cdh1 (FZR1) in MCF-10A breast epithelial cells increased cyclin D1 protein expression. Like C/EBPdelta, and in contrast to cyclin D1, Cdc27 was down-regulated in several breast cancer cell lines, suggesting that Cdc27 itself may be a tumor suppressor. Cyclin D1 is a known substrate of polyubiquitination complex SKP1/CUL1/F-box (SCF), and our studies show that Cdc27 directs cyclin D1 to alternative degradation by APC/C. These findings shed light on the role and regulation of APC/C, which is critical for most cellular processes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20439707      PMCID: PMC2889124          DOI: 10.1073/pnas.0913813107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

Review 1.  The anaphase promoting complex/cyclosome: a machine designed to destroy.

Authors:  Jan-Michael Peters
Journal:  Nat Rev Mol Cell Biol       Date:  2006-08-09       Impact factor: 94.444

2.  A gene-expression signature to predict survival in breast cancer across independent data sets.

Authors:  A Naderi; A E Teschendorff; N L Barbosa-Morais; S E Pinder; A R Green; D G Powe; J F R Robertson; S Aparicio; I O Ellis; J D Brenton; C Caldas
Journal:  Oncogene       Date:  2006-08-28       Impact factor: 9.867

3.  Promoter methylation reduces C/EBPdelta (CEBPD) gene expression in the SUM-52PE human breast cancer cell line and in primary breast tumors.

Authors:  D Tang; G S Sivko; J W DeWille
Journal:  Breast Cancer Res Treat       Date:  2005-12-02       Impact factor: 4.872

4.  C/EBPdelta is a crucial regulator of pro-apoptotic gene expression during mammary gland involution.

Authors:  Muthusamy Thangaraju; Martina Rudelius; Brian Bierie; Mark Raffeld; Shikha Sharan; Lothar Hennighausen; A-Mei Huang; Esta Sterneck
Journal:  Development       Date:  2005-09-28       Impact factor: 6.868

5.  CCAAT/enhancer-binding protein delta regulates mammary epithelial cell G0 growth arrest and apoptosis.

Authors:  J P O'Rourke; G C Newbound; J A Hutt; J DeWille
Journal:  J Biol Chem       Date:  1999-06-04       Impact factor: 5.157

Review 6.  Cyclin D1 and breast cancer.

Authors:  Pankaj G Roy; Alastair M Thompson
Journal:  Breast       Date:  2006-05-03       Impact factor: 4.380

7.  A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes.

Authors:  Richard M Neve; Koei Chin; Jane Fridlyand; Jennifer Yeh; Frederick L Baehner; Tea Fevr; Laura Clark; Nora Bayani; Jean-Philippe Coppe; Frances Tong; Terry Speed; Paul T Spellman; Sandy DeVries; Anna Lapuk; Nick J Wang; Wen-Lin Kuo; Jackie L Stilwell; Daniel Pinkel; Donna G Albertson; Frederic M Waldman; Frank McCormick; Robert B Dickson; Michael D Johnson; Marc Lippman; Stephen Ethier; Adi Gazdar; Joe W Gray
Journal:  Cancer Cell       Date:  2006-12       Impact factor: 31.743

8.  Phosphorylation-dependent ubiquitination of cyclin D1 by the SCF(FBX4-alphaB crystallin) complex.

Authors:  Douglas I Lin; Olena Barbash; K G Suresh Kumar; Jason D Weber; J Wade Harper; Andres J P Klein-Szanto; Anil Rustgi; Serge Y Fuchs; J Alan Diehl
Journal:  Mol Cell       Date:  2006-11-03       Impact factor: 17.970

9.  Fbxw7 contributes to tumor suppression by targeting multiple proteins for ubiquitin-dependent degradation.

Authors:  Yo Fujii; Masayoshi Yada; Masaaki Nishiyama; Takumi Kamura; Hidehisa Takahashi; Ryosuke Tsunematsu; Etsuo Susaki; Tadashi Nakagawa; Akinobu Matsumoto; Keiichi I Nakayama
Journal:  Cancer Sci       Date:  2006-08       Impact factor: 6.716

Review 10.  The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention.

Authors:  John P Alao
Journal:  Mol Cancer       Date:  2007-04-02       Impact factor: 27.401

View more
  41 in total

1.  CCAAT/enhancer binding protein delta (C/EBPdelta, CEBPD)-mediated nuclear import of FANCD2 by IPO4 augments cellular response to DNA damage.

Authors:  Jun Wang; Tapasree Roy Sarkar; Ming Zhou; Shikha Sharan; Daniel A Ritt; Timothy D Veenstra; Deborah K Morrison; A-Mei Huang; Esta Sterneck
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-30       Impact factor: 11.205

2.  C/EBPδ: friend or foe? a novel role for C/EBPδ in metastasis.

Authors:  Facundo G Pelorosso; Allan Balmain
Journal:  EMBO J       Date:  2010-12-15       Impact factor: 11.598

3.  The tumour suppressor C/EBPδ inhibits FBXW7 expression and promotes mammary tumour metastasis.

Authors:  Kuppusamy Balamurugan; Ju-Ming Wang; Hsin-Hwa Tsai; Shikha Sharan; Miriam Anver; Robert Leighty; Esta Sterneck
Journal:  EMBO J       Date:  2010-11-12       Impact factor: 11.598

Review 4.  APC/C ubiquitin ligase: Functions and mechanisms in tumorigenesis.

Authors:  Morgan S Schrock; Benjamin R Stromberg; Luke Scarberry; Matthew K Summers
Journal:  Semin Cancer Biol       Date:  2020-03-09       Impact factor: 15.707

Review 5.  The role of aberrant proteolysis in lymphomagenesis.

Authors:  Anagh A Sahasrabuddhe; Kojo S J Elenitoba-Johnson
Journal:  Curr Opin Hematol       Date:  2015-07       Impact factor: 3.284

6.  The FBXO4 tumor suppressor functions as a barrier to BRAFV600E-dependent metastatic melanoma.

Authors:  Eric K Lee; Zhaorui Lian; Kurt D'Andrea; Richard Letrero; WeiQi Sheng; Shujing Liu; J Nathaniel Diehl; Dariusz Pytel; Olena Barbash; Lynn Schuchter; Ravi Amaravaradi; Xiaowei Xu; Meenhard Herlyn; Katherine L Nathanson; J Alan Diehl
Journal:  Mol Cell Biol       Date:  2013-09-09       Impact factor: 4.272

7.  GATA4 loss of function in liver cancer impedes precursor to hepatocyte transition.

Authors:  Francis O Enane; Wai Ho Shuen; Xiaorong Gu; Ebrahem Quteba; Bartlomiej Przychodzen; Hideki Makishima; Juraj Bodo; Joanna Ng; Chit Lai Chee; Rebecca Ba; Lip Seng Koh; Janice Lim; Rachael Cheong; Marissa Teo; Zhenbo Hu; Kwok Peng Ng; Jaroslaw Maciejewski; Tomas Radivoyevitch; Alexander Chung; London Lucien Ooi; Yu Meng Tan; Peng-Chung Cheow; Pierce Chow; Chung Yip Chan; Kiat Hon Lim; Lisa Yerian; Eric Hsi; Han Chong Toh; Yogen Saunthararajah
Journal:  J Clin Invest       Date:  2017-07-31       Impact factor: 14.808

Review 8.  Cyclin D degradation by E3 ligases in cancer progression and treatment.

Authors:  Shuo Qie; J Alan Diehl
Journal:  Semin Cancer Biol       Date:  2020-01-30       Impact factor: 15.707

9.  Association between polymorphisms in cdc27 and breast cancer in a Chinese population.

Authors:  Hui Guo; Wei Chen; Jie Ming; Rong Zhong; Pengfei Yi; Beibei Zhu; Xiaoping Miao; Tao Huang
Journal:  Tumour Biol       Date:  2015-02-14

10.  Identification of a Src tyrosine kinase/SIAH2 E3 ubiquitin ligase pathway that regulates C/EBPδ expression and contributes to transformation of breast tumor cells.

Authors:  Tapasree Roy Sarkar; Shikha Sharan; Jun Wang; Snehalata A Pawar; Carrie A Cantwell; Peter F Johnson; Deborah K Morrison; Ju-Ming Wang; Esta Sterneck
Journal:  Mol Cell Biol       Date:  2011-10-28       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.